Biotechnology
Hydrogel keeps vaccines alive
Research
ETH Zurich
Most vaccines require constant refrigeration during shipment to remain effective. An international research team led by ETH Zurich has now developed a special hydrogel that vastly improves the shelf life of vaccines, even without refrigeration. The development could save many lives and lower the cost of cold chains.
From cell fat to cell fate
Research
EPFL
A cell’s production of fat molecules can be a key factor in determining what that cell will become, show scientists at EPFL.
In the heat of the wound
Research
Empa
A bandage that releases medication as soon as an infection starts in a wound could treat injuries more efficiently. Empa researchers are currently working on polymer fibers that soften as soon as the environment heats up due to an infection, thereby releasing antimicrobial drugs.
A new dimension in transplantation
Research
ETH Zurich
In a technological breakthrough, researchers at ETH Zurich have announced the development of a new technique that can transplant mitochondria – the tiny powerhouses of the cell – from one living cell to another with unparalleled efficiency.
EPFL spin-off develops protein to boost immunotherapy
TechTransfer
EPFL
EPFL spin-off Leman Biotech has developed a protein that can improve the effectiveness of immunotherapy drugs used to treat some types of cancer. The firm has just completed its first funding round, in the amount of $11 million.
AI offers a faster way to predict antibiotic resistance
Research
ETH Zurich
A study under co-leadership of the ETH Zurich has shown that computer algorithms can determine antimicrobial resistance of bacteria faster than previous methods. This could help treat serious infections more efficiently in the future.
Page 6 of 9